Skip to main content

SRPT

Sarepta Therapeutics, Inc.

Company with tickers: SRPT

Market Cap
$1.76B
Shares Outstanding
105,576,222
CIK
873303
CUSIP
803607100
13F Activity (30d)
30 filings 6 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$500,000,000
as of 2024-11-30 · not restated in filings since 2025-02-28
Remaining Authorization
$475,000,000
as of 2025-12-31
Program Utilization
5.0% $25,000,000 used of $500,000,000

Repurchase History

Fiscal Year Ended Cash Spent
2025-12-31 $25,013,000
2024-12-31 $0
2023-12-31 $0
2012-09-30 $289,000
2012-06-30 $289,000
2012-03-31 $289,000
2011-12-31 $289,000
2011-09-30 $289,000
2011-06-30 $289,000